You searched for "oncology"

661 results found

The unknown primary again

In this retrospective study of 35 patients, the authors followed a systematic protocol for the detection and management of malignant cervical lymph nodes without an apparent primary lesion. Although their one, three and five year survival results are consistent with...

Harnessing head and neck cancer genomics for personalised medicine

Luc Morris updates us on the future of cancer diagnosis and treatment, which lies in “personalised oncology”, where specific molecular alterations of each tumour will be identified, and matched with actionable alterations in existing therapies, ushering in the era of...

The stigma of HPV in oral cancer

The increase of oropharyngeal carcinoma (OPC) in the developed world seems to be largely caused by infection with the human papillomavirus (HPV). HPV is a group of 150 DNA viruses that are common and most people will be infected at...

In conversation with Professor Jatin Shah

We are honoured to welcome renowned head and neck surgeon, Professor Jatin Shah as Guest Editor of this edition of ENT and Audiology News. Here he speaks to Section Editor, Charlie Giddings, about his career, memorable achievements and advice for...

In conversation: Cesare Piazza and Giuseppe Spriano

Declan Costello catches up with the presidents of two important meetings taking place in Italy in June 2023 to discuss the highlights.

British Skull Base Society Clinical Consensus Document on Management of Head and Neck Paragangliomas (HNPGLs)

All forms of HNPGLs should be managed by a multidisciplinary team (MDT) of core members from skull base otolaryngology, head and neck surgery, clinical genetics, oncology, endocrinology, vascular surgery, radiology and pathology. Extended members include neurosurgery, endocrine surgery, nuclear medicine,...

Core biopsies are good enough for lymphomas

This paper, from the South of England, has reviewed ultrasound-guided core needle biopsies over a six-year period investigating the use of the detection of head and neck lymphomas. There were 367 samples included from 226 patients; 215 of the 226...

KTP laser ablation for early glottic cancer

TLM for glottic carcinoma has historically been performed with a carbon dioxide (CO2) laser. A much smaller literature base has examined the use of potassium titanyl phosphate (KTP) laser in this context. This retrospective chart review aims to fill that...

Robotic head and neck surgery: current state of the art and future innovations

Technology and innovation has provided modern head and neck surgeons with successive generations of robotic surgical systems, fibre-optic lasers, and novel tools which have ushered in a new era of minimally invasive surgery for tumours of the pharynx and larynx....

Audiology in this issue...The Weird World of Science

Gareth Smith, Consultant Clinical Scientist (Audiology), Southend University Hospital, UK. E: Gareth.Smith@southend.nhs.uk Twitter: @garethlsmith In this edition, I’ve taken rather an editor’s privilege in exploring outside of our mainstays in audiology and widened the field to consider acoustics more widely...

All change at International Newsround

ENT & Audiology News has two new ENT editors who have joined Audiology Editor Keiran Joseph on the International Newsround section. After six years in the role, Emma Stapleton has handed over to Rohma Abrar and Haseem Raja. “They are...

Grading dysphagia as a toxicity in treating head and neck cancer

Common Terminology Criteria for Adverse Events (CTCAE) is a system used by clinicians to grade the toxicity of oncology treatments in a standardised manner. Dysphagia is perhaps the most common long-term toxicity of head and neck cancer treatment. Currently, a...